QUOUR
LIVE

Serial Number

79358950

Owner

Apleonex AG

Attorney

Nicholas D. Wells

Filing Date

Oct 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

QUOUR Trademark

Serial Number: 79358950 • Registration: 7772518

QUOUR is a trademark filed by Apleonex AG on October 25, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 34 (Smokers Articles), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Apleonex AG

Hermannstraße 16

Entity Type: 25

Trademark Details

Filing Date

October 25, 2022

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Sensors, detectors and monitoring instruments, namely, alarm sensors, timing sensors, motion sensors, smoke detectors, radar detectors, temperature sensors; Downloadable medical software for providing and faciliting medical diagnosis, and for managing data and communications related to clinical trials, pharmaceutical, scientific, biological and clinical research for use in the fields of medicine, biothechnology, pharmacology, drug discovery and development; data and file management software and database software, namely downloadable computer software for providing database management in the field of providing medical diagnosis, clinical trials, pharmaceutical, scientific, biological and clinical research for use in the fields of medicine, biothechnology, pharmacology, drug discovery and development; data management software, namely, downloadable computer software for managing electronic data; Downloadable software for recording, analysis, evaluation and reporting of data

Medical and pharmacological research services; research and development in the field of biotechnology; Medical laboratory services; research laboratories, namely, laboratory research in the fields of bacteriology, biotechnology; analytical medical laboratory services; clinical research in the field of pharmacology; information agency services, namely, providing medical and scientific research information in the field of clinical trials; provision of information relating to scientific research in the fields of cardiology, dermatology, the prevention, treatment and management of illness, hepatology, diabetes, obesity and metabolism, hypertension, hemostaseology, endometriosis, oncology, neurology, autoimmunology and infectiology; testing, authentication and quality control, namely, testing, analysis, and evaluation of small molecules, biotechnological products, medical devices and application systems and digital health solutions to assure compliance with pharmaceutical and medical safety, quality and regulatory industry standards; pharmaceutical drug and medicine development; consultancy relating to biotechnology; Pharmaceutical research services in the nature of searching, identifying and assessing candidate pharmaceutical substances; quality control monitoring and auditing in the nature of monitoring small molecules, biotechnological products, medical devices and application systems and digital health solutions for quality control purposes; preparation of scientific reports in the nature of providing scientific information in the fields of biotechnology, clinical pharmacology, drug discovery, drug development; software as a service (SaaS) services featuring software for use in clinical database management, and rental of computer software for processing, diagnosing and analyzing medical data; product development

Medical preparations and articles, namely, medical preparations for the treatment of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma allergy, cancer, autoimmune diseases, neurological diseases and infectious diseases; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; dietary supplements and dietetic preparations adapted for medical purposes; pharmaceuticals in the nature of pharmaceutical preparations for the treatment and prevention of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma, allergy, autoimmune diseases and infectious diseases and natural remedies in the nature of natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; homeopathic medicines and pharmaceuticals, namely, homeopathic pharmaceuticals for use in the treatment of cardiac arrhythmias, hypertension, pneumonia, diabetes, obesity and metabolism, asthma, allergy, autoimmune diseases and infectious diseases; biotechnological preparations for medical use in the nature of pharmaceutical preparations for the treatment and prevention of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, endometriosis, asthma and allergy; biotechnological pharmaceutical preparations for gene and cell therapy, all being for medical purposes; Colostral antibodies for medical purposes; sanitary preparations and articles, namely, sanitary preparations for medical use; vaccines; reagents for medical use; medical dressings, plasters and applicators in the nature of swabs for medical purposes, wound dressings, adhesive plasters for wound care, cotton sticks for medical purposes and pre-filled syringes with pharmaceutical preparations, namely, pre-filled syringes filled with insulin for medical purposes

Medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate; diagnostic, examination, and monitoring equipment, namely, medical devices for use in diagnosing of cardiac arrhythmias, encephalitis, hypertension, pneumonia, diabetes, obesity and metabolism, hypertension, endometriosis, asthma, endometriosis, renal impairment, hepatology, hemostaseology, cancer, autoimmune diseases, neurological diseases and infectious diseases; testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA; artificial limbs; injectors for medical purposes, namely, medical fluid injectors; inhalers for medical purposes, sold empty; medical instruments for use in treating cardiac arrhythmias and hypertension; measuring instruments adapted for medical use, namely, medical instruments for measuring blood pressure, lung capacity; medical apparatus used in the manufacture of drugs, medical products and medical apparatus, namely, medical apparatus for use in treating respiratory diseases, cardiovascular diseases, rheumatoid arthritis; prosthetics in the nature of prosthetic limbs, namely, arms, feet, legs and artificial implants in the nature of surgical implants comprised of artificial materials; surgical and wound treating equipment, namely, surgical instruments for use in orthopedic surgery, in general surgery; medical diagnostic apparatus and equipment, namely, medical diagnostic apparatus for testing the heart conditions, medical diagnostic apparatus for use in the fields of cancer, cell-based testing; clothing especially for operating rooms, orthodontic headgear and orthopedic footwear, medical braces for knee, ankle, elbow and supports for ankle, wrist, for medical purposes; physical therapy equipment, namely, physical therapy equipment in the nature of foam rollers, manually-operated resistance tubing, weighted balls; mobility aids, namely, walkers to aid mobility

Business consultancy and advisory services; business consultancy services relating to the supply of quality management systems; compilation of statistics; business assistance, management and administrative services; business administration; business consultancy relating to the preparation, creation and submission of permit applications including the authorities and ethics committees

Medical services; pharmaceutical services, namely, pharmaceutical compounding services; animal healthcare services; information and counselling services in the field of medicine and preparation of prescriptions in pharmacies; advisory services relating to medical services

Articles for use with tobacco, namely, tobacco grinders; personal oral vaporizers for smoking purposes and electronic cigarettes, and flavourings and solutions therefor in the nature of chemical flavourings in liquid form used to refill electronic cigarette cartridges

Investment services, namely, private equity fund investment services, real estate investment services; business investment services, namely, hedge fund investment services; financial information, data analysis, advice and consultancy services, financial credit assessment and credit information in the nature of credit rating services, financial appraisal services in responding to calls for tenders, financial planning services, financing and funding services in the nature of venture capital funding services to emerging and start-up companies, venture capital services in the nature of venture capital financing; fundraising services by means of organizing, arranging and conducting fundraising programs for the benefit of youth sports programs, schools, non-profit organizations, and financial sponsorship of charitable events, cultural events, concerts, sporting events, festivals, and awards shows; valuation services, namely, financial valuations

Provision of training and further training, namely, training services in the fields of biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug development, clinical trials, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research, investigation of drug-drug and food-drug interactions; organizing and conducting seminars, webinars, workshops, congresses and conferences in the fields of biotechnology, medicine, pharmacology, investigation of drug-drug and food-drug interactions; conducting of online seminars in the fields of biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug development, clinical trials, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research investigation of drug-drug and food-drug interactions; publication of scientific research papers, books, magazines in the field of printed matters and digital media relating to clinical trials, drug development, biotechnology, medicine, pharmacology, pharmacy, pharmaceutics, drug regulatory affairs, clinical data management, drug safety, quality management of clinical trials, biostatistics, lab analytics and pre-clinical research, investigation of drug-drug and food-drug interactions

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 14, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 13, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 15, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 15, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 18, 2024 GNFN
FINAL REFUSAL E-MAILED
Nov 18, 2024 GNFR
FINAL REFUSAL WRITTEN
Nov 18, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2024 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
REFUSAL PROCESSED BY IB
May 8, 2024 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 10, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 4, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 19, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 18, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 9, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 30, 2022 REPR